The lead technology is FiCAT, a best-in-class platform geared towards resolving the current limitations on gene writing: size, precision, and stability. FiCAT combines the precision of CRISPR-Cas and the transfer efficiency of an engineered piggyBac transposase protein with the capability to deliver small and large payloads.
The Goal
“To manifest the advanced therapies in genetic and oncological diseases”.
Challenge
Outstanding animation feature: accurately showing the key message.
It was important to use a simple 3D animation to scientifically accurately show the key point.
Integra Therapeutic has engineered a machine that can integrate genes of any size into the genome in an efficient and precise manner. The animation shows in detail how the piggyBac transposase inside the cell provides efficient and accurate insertion of the therapeutic gene of almost any size into the genome.
Our Approach
Taking into account the vision of the client in combination with professional recommendations from our side – brings the best result.
We take into consideration all the wishes and requirements of the client, and at the same time, our team always provides highly qualified advice on visual implementation and compliance with the correctness of the picture from a medical point of view. The healthy cell is demonstrated with a nucleus and chromosomes to show how the FiCAT unlocks the potential of programmable transposition gene writing modality.
Results
3D Light animation, demonstrating the basic principle of the leading FiCAT technology and what problems it is aimed at solving.
Project in numbers
6 weeks: Duration from the idea to the final delivery of the video (38 sec).
4 meetings: Communication with client is essential for us. To listen to them and provide with the best result.
2 rounds: Two feedback rounds on the production stage.
We are sincerely delighted that our animation achieved our client’s objective and garnered positive feedback:
“I have really enjoyed the creative process of generating this video with the Nanobot medical team; they understood our goal and were willing to accommodate our needs. In addition, it was a blast working with such a high-performing team of women in STEM and design!” — Avencia Sánchez-Mejías, PhD – Co-founder at Integra Therapeutics
